Total Funding
55
66
Total FundingSeries A raised
Growth Score 55 in past quarter
-7 pts
Heat Score 66 in past quarter
-7 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
20596
Daye is a gynecological health company that creates products and services for vaginal treatment.
- Hannah Allen: Chief Medical Officer
- Valentina Milanova: Founder and CEOPast Role: Founders Factory, Venture Associate
About the Company
Daye is a gynecological health company that creates products and services for vaginal treatment. Its tampon-based at-home vaginal microbiome screening kit allows women to test themselves at their leisure. The kit is intended to screen for vaginal infections such as thrush and bacterial vaginosis (BV), as well as disruptions to the microbiome, which
could put women at risk of STIs, gynecological cancers, and fertility and IVF complications. Daye will also launch a comprehensive digital platform for gynae health, with the goal of reducing pain, shame, and wasted time for women as they navigate their health journey from their first period to menopause.
The company was founded in 2017